Is Participation in Cancer Phase I Trials Really Therapeutic?
- PMID: 27646944
- PMCID: PMC5321666
- DOI: 10.1200/JCO.2016.67.9902
Is Participation in Cancer Phase I Trials Really Therapeutic?
Conflict of interest statement
Comment in
-
Reaffirming and Clarifying the American Society of Clinical Oncology's Policy Statement on the Critical Role of Phase I Trials in Cancer Research and Treatment.J Clin Oncol. 2017 Jan 10;35(2):139-140. doi: 10.1200/JCO.2016.70.4692. Epub 2016 Nov 28. J Clin Oncol. 2017. PMID: 27893329 Free PMC article. No abstract available.
-
A Rationale for Relaxing the Requirement to Undergo a Noncurative Chemotherapy for Advanced Cancer in a Phase I Immunotherapy Trial.Am J Bioeth. 2017 Apr;17(4):68-69. doi: 10.1080/15265161.2017.1284922. Am J Bioeth. 2017. PMID: 28328363 No abstract available.
Similar articles
-
The prognosis of prognostic factors in phase I clinical trials.Ann Oncol. 2000 Feb;11(2):131-2. doi: 10.1023/a:1008327527877. Ann Oncol. 2000. PMID: 10761746 No abstract available.
-
Health care disparity: an overlooked problem in phase I oncology trials.J Clin Oncol. 2007 Jul 20;25(21):3182-3. doi: 10.1200/JCO.2007.11.4512. J Clin Oncol. 2007. PMID: 17634502 No abstract available.
-
Discrete event simulation applied to pediatric phase I oncology designs.Clin Pharmacol Ther. 2008 Dec;84(6):729-33. doi: 10.1038/clpt.2008.193. Epub 2008 Oct 15. Clin Pharmacol Ther. 2008. PMID: 18923388 Review. No abstract available.
-
Outcomes of patients ≥65 years old with advanced cancer treated on phase I trials at MD ANDERSON CANCER CENTER.Int J Cancer. 2017 Jan 1;140(1):208-215. doi: 10.1002/ijc.30417. Epub 2016 Oct 17. Int J Cancer. 2017. PMID: 27599876
-
Novel endpoints and design of early clinical trials.Ann Oncol. 2002;13 Suppl 4:139-43. doi: 10.1093/annonc/mdf651. Ann Oncol. 2002. PMID: 12401680 Review. No abstract available.
Cited by
-
Phase I trials as valid therapeutic options for patients with cancer.Nat Rev Clin Oncol. 2019 Dec;16(12):773-778. doi: 10.1038/s41571-019-0262-9. Epub 2019 Sep 2. Nat Rev Clin Oncol. 2019. PMID: 31477881 Free PMC article. Review.
-
Reaffirming and Clarifying the American Society of Clinical Oncology's Policy Statement on the Critical Role of Phase I Trials in Cancer Research and Treatment.J Clin Oncol. 2017 Jan 10;35(2):139-140. doi: 10.1200/JCO.2016.70.4692. Epub 2016 Nov 28. J Clin Oncol. 2017. PMID: 27893329 Free PMC article. No abstract available.
-
Before Consent: Qualitative Analysis of Deliberations of Patients With Advanced Cancer About Early-Phase Clinical Trials.JCO Oncol Pract. 2020 Jan;16(1):e56-e63. doi: 10.1200/JOP.19.00256. Epub 2019 Oct 11. JCO Oncol Pract. 2020. PMID: 31603726 Free PMC article.
-
Proportion of patients in phase 2 oncology trials receiving treatments that are ultimately approved.J Natl Cancer Inst. 2025 May 1;117(5):1056-1063. doi: 10.1093/jnci/djaf013. J Natl Cancer Inst. 2025. PMID: 39994861 Free PMC article.
-
Early drug development in solid tumours: analysis of National Cancer Institute-sponsored phase 1 trials.Lancet. 2022 Aug 13;400(10351):512-521. doi: 10.1016/S0140-6736(22)01390-3. Lancet. 2022. PMID: 35964611 Free PMC article.
References
-
- Miller FG, Joffe S. Benefit in phase I oncology trials: therapeutic misconception or reasonable treatment option? Clin Trials. 2008;5:617–23. - PubMed
-
- Schüklenk U, Lowry C. Terminal illness and access to phase I experimental agents, surgeries and devices: reviewing the ethical arguments. Br Med Bull. 2009;89:7–22. - PubMed
-
- Ross L. Phase I research and the meaning of direct benefit. J Pediatr. 2006;149:S20–4. - PubMed
-
- Miller M. Phase I cancer trials. A collusion of misunderstanding. Hastings Cent Rep. 2000;30:34–43. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources